After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $8.74 and fluctuated between $8.88 as its day high and $8.21 as its day low. The current market capitalization of Cytek BioSciences Inc is $1.18B. A total of 0.69 million shares were traded on the day, compared to an average of 786.97K shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, CTKB has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 3,000 shares. Over the last 12 months, there were 27 BUYs and 52 SELLs from insiders. Insiders purchased 93,831 shares during that period but sold 2,688,269.
In the most recent transaction, Jeanmonod Patrik sold 3,000 shares of CTKB for 9.50 per share on Dec 26. After the transaction, the Chief Financial Officer now owns 93,400 company shares. In a previous transaction on Dec 19, Yan Ming sold 20,000 shares at 9.43 per share. CTKB shares that Chief Technology Officer owns now total 6,042,103.
Among the insiders who sold shares, Jeanmonod Patrik disposed of 3,000 shares on Nov 24 at a per-share price of $6.94. This resulted in the Chief Financial Officer holding 96,400 shares of CTKB after the transaction. In another insider transaction, Yan Ming sold 20,000 shares at $6.03 per share on Nov 20. Company shares held by the Chief Technology Officer now total 7,762,103.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for CTKB in the last 3 months, the mean price target is $10.00 with high estimates of $12.00 and low estimates of $7.00. In terms of 52-week highs and lows, CTKB has a high of $12.31 and a low of $3.80.
As of this writing, CTKB has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.02 per share and a lower estimate of -$0.01. The company reported an EPS of -$0.03 in the last quarter, which was -200.00% lower than expectations of $0.03.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CTKB’s latest balance sheet shows that the firm has $364.62M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $33.18M in liabilities at the time. Its Book Value Per Share was $3.07, while its Total Shareholder’s Equity was $405.38M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTKB is Buy with a score of 4.33.
